Search Form
First, enter a politician or zip code
Now, choose a category
 

Chuck Grassley's Public Statements on Issue: Drugs

Office: U.S. Senate (IA) - Sr, Republican
Date Title
April 4, 2017 Letter to Chuck Rosenberg, Acting Administrator, U.S. Drug Enforcement Administration - Provide Answers on Resistance to Recommended Policy Changes in Wake of Review following Agent's Death
March 28, 2017 Grassley, Feinstein Bill Combats Candy- and Fruit-Flavored Drugs Marketed to Children
Feb. 14, 2017 Letter to the Honorable Tom Price, Secretary of Health and Human Services - Permit Safe Importation of Prescription Drugs from Canada
Jan. 25, 2017 Grassley on Bipartisan Legislation to Help Fight Dangerous Synthetic Drugs
Jan. 4, 2017 Letter to The Hon. Andrew M. Slavitt, Acting Administrator of Centers for Medicare & Medicaid Services - Pressing Administration on EpiPen, Dliaudid, Prilosec Misclassifications
Jan. 1, 2017 Issue Position: Drugs
Dec. 13, 2016 Letter to President-Elect Donald J. Trump - Prioritize Fixing Medicaid Drug Misclassifications
Dec. 9, 2016 Grassley: Watchdog is Right to Review Misclassifications Under Medicaid Drug Rebate Program
Dec. 8, 2016 Grassley, HHS Secretary Nominee Price Discuss Rural Hospitals, Medicaid Oversight, Soaring Drug Prices and Remedies
Dec. 7, 2016 EpiPen Misclassification is Case Study in What Not to Do, Grassley Tells CMS Administrator Nominee
Dec. 6, 2016 Grassley Continues Push to Combat Rising Drug Prices
Nov. 17, 2016 Administration Takes Steps to Implement Key Medication-assisted Treatment Provision in Grassley-Led Opioid Treatment Bill
Oct. 19, 2016 Grassley Encourages Iowans to Participate in Prescription Drug Take Back Day This Saturday
Oct. 11, 2016 Grassley Presses Justice Department for Details of Mylan Settlement Over EpiPen Overcharges
Oct. 6, 2016 EpiPens: Grassley Finds Substantial Revenue Growth to Mylan from Taxpayers Via Medicare, Medicaid
Oct. 4, 2016 Grassley Presses EpiPen Maker, Federal Agency on Medicaid Classification
Sept. 20, 2016 Letter to the Honorable Daniel Levinson, Inspector General of the Dept. of Health and Human Services - Call for Review of Rebate Practices for Mylan's EpiPen
Sept. 16, 2016 Letter to the Honorable John Kerry, Secretary of the Dept. of State - Address Trafficking of Synthetic Drugs and Illicit Goods Through Mail Service
Aug. 29, 2016 EpiPen Maker Announces Generic Product; Grassley Looks Forward to Details, Written Responses to His Inquiries
Aug. 24, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration - Account for Any Alternatives to the EpiPen Amid Product Cost Increase
Aug. 4, 2016 Letter to Chuck Rosenberg, Acting Administrator of the Drug Enforcement Administration - Request Update on DEA Efforts to Monitor Controlled Substances Prescribers
July 22, 2016 Landmark Addiction Recovery Bill Signed into Law
July 15, 2016 Grassley, Schumer Bill Bans Dangerous & Deceptive Synthetic Drugs
July 13, 2016 Senate Sends Landmark Addiction Recovery Bill to President
July 12, 2016 Comprehensive Addiction and Recovery Act of 2016--Conference Report--
July 8, 2016 Grassley Statement on House Passage of Bipartisan Addiction Recovery Bill
July 7, 2016 House-Senate Opioid Conference Report Finalized
July 6, 2016 Grassley Leads Senate Delegation Finalizing Landmark Addiction Recovery Bill
July 5, 2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic
June 27, 2016 Letter to the Honorable Jeh Johnson, Secretary of Homeland Security - Undocumented Criminal
June 22, 2016 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Hearing on Oversight of the Drug Enforcement Administration
June 16, 2016 Finance Senators Introduce Family First Prevention Services Act
June 7, 2016 Hearing of the Senate Judiciary Committee - Chairman's Statement on "Deadly Synthetic Drugs: The Need to Stay Ahead of the Poison Peddlers"
May 17, 2016 Two More Judiciary Committee Bills Signed into Law
May 17, 2016 Grassley Seeks Answers on Wasted $86 Million for Drug Interdiction Plane for Afghanistan
May 16, 2016 Grassley, Feinstein Seek Update on Agencies' Scientific, Medical Evaluation of Cannabidiol
May 10, 2016 Grassley, Klobuchar Introduce Bill to Protect Classified Information Used to Designate Foreign Narcotics Kingpins
May 10, 2016 Grassley, Feinstein Praise House Passage of Bill to Fight Transnational Drug Trafficking; Bill Heads to President's Desk
April 28, 2016 National Prescription Drug Take Back Day
April 27, 2016 Hearing of the Senate Judiciary Committee - Chairman Grassley's Opening Statement on "Counterfeits and Their Impact on Consumer Health and Safety"
April 15, 2016 Grassley, Feinstein Urge CMS to Press Hospitals on Avoiding Unnecessary Opioids
April 4, 2016 Defend Trade Secrets Act of 2015
March 31, 2016 Letter to Gene Dodarco, Comptroller General of the United States, Government Accountability Office - Federal Drug Take Back Programs
March 29, 2016 Administration Too Slow on Certain Anti-opioid Measures, Sends Mixed Message on Marijuana
March 29, 2016 Administration Too Slow on Certain Anti-opioid Measures, Sends Mixed Message on Marijuana
March 10, 2016 Comprehensive Addiction and Recovery Act of 2015
March 10, 2016 Senate Accomplishments
March 10, 2016 Grassley Leads Bipartisan Addiction Recovery Bill to Passage in Senate
March 3, 2016 Comprehensive Addiction and Recovery Act of 2015
March 2, 2016 Comprehensive Addiction and Recovery Act of 2015
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top